Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer Diagnosis.


Journal

JAMA oncology
ISSN: 2374-2445
Titre abrégé: JAMA Oncol
Pays: United States
ID NLM: 101652861

Informations de publication

Date de publication:
01 05 2022
Historique:
pubmed: 1 4 2022
medline: 24 5 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Nonfatal self-injury (NFSI) is a patient-centered manifestation of severe distress occurring in 3 out of 1000 patients after cancer diagnosis. How to identify patients at risk for NFSI remains unknown. To examine the associations between patient-reported outcome measures and subsequent NFSI in patients with cancer. This population-based matched case-control study included adults with a new cancer diagnosis reporting an Edmonton Symptom Assessment System (ESAS) score within 36 months of diagnosis in Ontario, Canada, 2007 to 2019. Data analysis was performed January 2007 to December 2019. Cases included patients with NFSI, and controls were patients without NFSI. Cases and controls were matched 1:4. Multivariable conditional logistic regression assessed the association between moderate to severe ESAS symptom scores and total ESAS (t-ESAS, range 0-90) score with NFSI in the subsequent 180 days. Of 408 858 patients reporting 1 or more ESAS assessments, 425 patients experienced NFSI and reported an ESAS score in the preceding 180 days. Of those, 406 cases were matched to 1624 control patients without an NFSI. Cases reported a higher proportion of moderate to severe symptoms and higher t-ESAS score than controls prior to the event. After adjustment, moderate to severe anxiety (odds ratio [OR], 1.61; 95% CI, 1.14-2.27), depression (OR, 1.66; 95% CI, 1.20-2.31), and shortness of breath (OR, 1.65; 95% CI, 1.18-2.31) and each 10-point increase in t-ESAS score (OR, 1.51; 95% CI, 1.40-1.63) were independently associated with higher odds of subsequent NFSI. In this case-control study, reporting moderate to severe anxiety, depression, and shortness of breath and an increasing t-ESAS score after cancer diagnosis were associated with higher odds of NFSI in the following 180 days. These data support the prospective use of routine ESAS screening as a means of identifying patients at higher risk for NFSI to improve supportive care.

Identifiants

pubmed: 35357419
pii: 2790726
doi: 10.1001/jamaoncol.2022.0203
pmc: PMC8972147
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e220203

Investigateurs

Barbara Haas (B)
Stephanie Mason (S)
Nicole Look-Hong (N)
Janet Ellis (J)
Lesley Goltib Conn (L)
Karen Fergus (K)
Craig Earle (C)
Kiersty Hong (K)

Auteurs

Julie Hallet (J)

Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Division of Surgical Oncology, Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Clinical Evaluative Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.

Rinku Sutradhar (R)

Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.

Elie Isenberg-Grzeda (E)

Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Psychosocial Oncology, Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Christopher W Noel (CW)

Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Canada.

Alyson L Mahar (AL)

Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Simone N Vigod (SN)

Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Department of Psychiatry, Women's College Hospital and Research Institute, Toronto, Ontario, Canada.

James Bolton (J)

Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada.

Julie Deleemans (J)

Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Wing C Chan (WC)

ICES, Toronto, Ontario, Canada.

Natalie G Coburn (NG)

Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Division of Surgical Oncology, Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Clinical Evaluative Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.

Antoine Eskander (A)

Division of Surgical Oncology, Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Clinical Evaluative Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH